Patent details

EP1725261 Title: USE FOR INTERLEUKIN-33 (IL-33) AND THE IL-33 RECEPTOR COMPLEX

Basic Information

Publication number:
EP1725261
PCT Application Number:
PCT/US/2005/004743
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057135774
PCT Publication Number:
WO/2005/079844
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE FOR INTERLEUKIN-33 (IL-33) AND THE IL-33 RECEPTOR COMPLEX
French Title of Invention:
UTILISATION D'AGONISTES ET D'ANTAGONISTES D'INTERLEUKINE-33 (IL-33)
German Title of Invention:
VERWENDUNG FÜR INTERLEUKIN-33 UND DEN IL-33 REZEPTORKOMPLEX
SPC Number:

Dates

Filing date:
15/02/2005
Grant date:
26/01/2011
EP Publication Date:
26/01/2011
PCT Publication Date:
01/09/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/11/2006
EP B1 Publication Date:
26/01/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/02/2011
Expiration date:
15/02/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/04/2024
 
 

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Avenue, Rahway, New Jersey 07065-0907, United States (US)

History of Owners

From:
19/07/2012
To:
05/04/2024

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, 07065-0907, Rahway NJ, United States (US)

Inventor

1

Name:
KASTELEIN Robert, A.
Address:
United States (US)

2

Name:
SCHMITZ Jochen
Address:
United States (US)

3

Name:
BAZAN J. Fernando
Address:
United States (US)

4

Name:
OFT Martin
Address:
United States (US)

Priority

Priority Number:
545730 P
Priority Date:
17/02/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202419
Publication date:
08/05/2024
Description:
Transfer of Rights
Filing date Document type Number of pages